Home » Topics » BioWorld Science

BioWorld Science
RSS

pH Pharma and Immunome collaborate to discover ADCs for cancer

Oct. 22, 2019

First patient with IPF dosed in phase I study of IDL-2965

Oct. 22, 2019

Imugene provides update on its CF-33 oncolytic virus clinical program

Oct. 22, 2019

C-781: a promising compound for mechanical allodynia

Oct. 22, 2019

Suven Life Sciences presents preclinical data for SUVN-A6077

Oct. 22, 2019

First-in-human data presented for NJA-730

Oct. 22, 2019

Identification of first FA-T case caused by homozygous missense variants in UBE2T

Oct. 22, 2019

VWA2 identified as a novel autosomal recessive gene candidate in AD

Oct. 22, 2019

Two novel mutations in the HIBCH gene linked to HIBCH deficiency

Oct. 22, 2019

Slc7a7 knockout mice display features of lysinuric protein intolerance

Oct. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...